Alon Gurfinkel

Davis Polk advised the initial purchasers in connection with a $370 million Regulation S only offering by Logan Property Holdings Company Limited of its 8.75% senior notes due 2020…

Davis Polk advised Notre Dame Intermédica Participações S.A. in connection with the equity offering by Notre Dame Intermédica and by Bain Capital, the controlling shareholder of Notre Dame…

Davis Polk advised the underwriters on the SEC-registered initial public offering by MOGU Inc. of 4,750,000 American Depositary Shares, each representing 25 Class A ordinary shares,…

Davis Polk is advising Mereo BioPharma Group plc on its combination with OncoMed Pharmaceuticals, Inc. The transaction, which is subject to customary closing conditions and the approval of…

Davis Polk advised the administrative agent and the joint lead arrangers in connection with the amendment and restatement of a $550 million senior secured revolving credit facility for FTI…

Davis Polk advised the initial purchasers in connection with a Rule 144A and Regulation S offering by iQIYI, Inc. of $750 million aggregate principal amount of its 3.75% convertible…

Davis Polk advised the joint book-running managers in connection with a Rule 144A/Regulation S offering of $500 million aggregate principal amount of 4.278% senior notes due 2028 by…

Davis Polk advised Tongcheng-Elong Holdings Limited in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance on…

Davis Polk advised CNFinance Holdings Limited on its SEC-registered initial public offering of 6,925,000 American Depositary Shares, including the partial exercise of the underwriters’…

Davis Polk advised the initial purchasers of a Regulation S offering of high-yield notes by Scenery Journey Limited (a subsidiary of China Evergrande Group) of $565 million aggregate…